| P2093 | author name string | M I Phillips | |
| | B L Maria | |
| | K B Hoang | |
| | C D Medina | |
| P2860 | cites work | The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats | Q42835030 |
| | Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant | Q45854779 |
| | Adenovirus-mediated gene therapy of experimental gliomas | Q45870226 |
| | Gene therapy for brain tumors in trials, correction of inherited disorders a hope | Q45875013 |
| | Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells | Q45876121 |
| | In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. | Q48164484 |
| | Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. | Q55481354 |
| | A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma | Q33374365 |
| | Targeting of an inducible toxic phenotype in animal cells | Q33654882 |
| | Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency | Q33850269 |
| | Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer | Q34194434 |
| | The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. | Q34294662 |
| | Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction | Q34354588 |
| | In vivo cytokine gene transfer by gene gun reduces tumor growth in mice | Q34513704 |
| | Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma | Q34616722 |
| | Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows | Q34734344 |
| | Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors | Q35228764 |
| | Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes | Q36230021 |
| | Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer | Q36230110 |
| | Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes | Q36346529 |
| | Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells | Q36349100 |
| | Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer | Q36745744 |
| | Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production | Q36918698 |
| | Progress toward human gene therapy | Q38646431 |
| | Retrovirus vectors: promise and reality | Q38727448 |
| | Retrovirus-mediated gene transfer in cancer therapy | Q40396909 |
| | Non-viral approaches to gene therapy | Q40401187 |
| | Transfer of genes to humans: early lessons and obstacles to success | Q40418899 |
| | Novel cellular therapies | Q40505323 |
| | Molecular neurosurgery: mending the broken brain | Q40535606 |
| | Gene therapy and pharmacological treatment of inherited neurological disorders | Q40535858 |
| | Retroviruses as vectors | Q40537182 |
| | Gene therapy and the brain | Q40537201 |
| | Gene therapy for solid tumors | Q40537219 |
| | Adenovirus and adeno-associated virus mediated gene transfer | Q40537236 |
| | Herpes virus-based vectors | Q40537241 |
| | Metabolic suicide genes in gene therapy | Q40561774 |
| | Nervous system modification by transplants and gene transfer | Q40582056 |
| | Human somatic gene therapy: progress and problems | Q40613034 |
| | Gene therapy of the immune system | Q40898198 |
| | The basic science of gene therapy | Q40907463 |
| | Nonviral gene therapy: the promise of genes as pharmaceutical products | Q40926330 |
| | Gene therapy. Molecular medicine of the 1990s | Q41054884 |
| | Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". | Q41275911 |
| | Bystander tumoricidal effect in the treatment of experimental brain tumors | Q41419847 |
| | Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model | Q41433356 |
| | Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer | Q41445691 |
| | Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system | Q41458222 |
| | An experimental model of retrovirus gene therapy for malignant brain tumors | Q41543855 |
| | Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir | Q41576545 |
| | Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line | Q41716747 |
| | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 |
| | In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors | Q42818740 |
| P433 | issue | 1 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Journal of Child Neurology | Q6294935 |
| P1476 | title | Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 1. The bench | |
| P478 | volume | 12 | |